Forex ziņas

Australian Market Significantly Lower

Extending the losses in the previous three sessions, the Australian stock market is significantly lower on Thursday, with the benchmark S&P/ASX 200 staying above the 7,100 level, mirroring the broadly negative cues from Wall Street overnight, as traders reacted to the US Fed's signals of keeping interest rates higher through 2024, despite the decision to hold interest rates steady this month.
RTTNews | 689 days ago
Canadian Market Ends Slightly Down

Canadian Market Ends Slightly Down

Despite spending much of the day's session in positive territory, the Canadian market ended slightly lower on Wednesday, extending its decline to a third straight day.
RTTNews | 689 days ago
Fed Leaves Interest Rates Unchanged But Forecasts Higher Rates For Longer

Fed Leaves Interest Rates Unchanged But Forecasts Higher Rates For Longer

In a widely anticipated move, the Federal Reserve announced on Wednesday that it has decided to leave interest rates unchanged. The Fed said it decided to maintain the target range for the federal funds rate at 5.25 to 5.50 percent after raising rates by 25 basis points in July.
RTTNews | 689 days ago
Swiss Market Ends Notably Higher

Swiss Market Ends Notably Higher

The Switzerland market ended notably higher on Wednesday, with investors picking up stocks, shrugging off a government report that said the nation's economy will expand significantly below average in both 2023 and 2024.
RTTNews | 689 days ago
more news
Euro Advances Amid Risk Appetite

Euro Advances Amid Risk Appetite

The euro was higher against its major counterparts in the European session on Wednesday amid risk appetite, as investors awaited the Fed's summary of economic projections and the updated quarterly rate projections — known as the dot plot —at the conclusion of a two-day policy meeting later in the day.
RTTNews | 690 days ago
Eli Lilly Sues Clinics Over Unauthorized Mounjaro Drug Sale

Eli Lilly Sues Clinics Over Unauthorized Mounjaro Drug Sale

Eli Lilly has filed lawsuits against several medical spas, wellness centers and compounding pharmacies for unauthorized sale of diabetes drug Mounjaro (tirzepatide). These clinics allegedly use the drug for weight loss treatment. Mounjaro, approved for type 2 diabetes, is only available from and manufactured by Lilly. They are commercially available in a pre-filled single-dose pen only.
RTTNews | 690 days ago

Stay up to date!

Add Ziņas to your browser

Extension Picture